lilly self pay tirzepatide Eli has launched new self-pay options for tirzepatide, introducing 7.5 mg and 10 mg single-dose vials for $499 through the Zepbound Journey Program. This initiative, available exclusively via LillyDirect Direct-to-consumer prescription drug programs: Plan

LifeScan Utilization Management and Formulary Deletion Product Removal & UM Changes : Due to LifeScans Chapter 11 bankruptcy, OneTouch diabetic test strips and meters will be removed from Highmarks Commercial and Exchange formularies starting September 15, 2025

Patients should contact their insurance plan to verify coverage details, including tier placement, prior authorization requirements, and out-of-pocket costs before filling prescriptions

View Abstract [9] Fernndez-Checa JC, Kaplowitz N, Garca-Ruiz C

The results of 157 preclinical testing are submitted to the FDA as part of an IND along with other information, including information about product chemistry, manufacturing and controls, and a proposed clinical trial protocol

doi: 10.1038/s41569-022-00824-4